However, previous research by Ferrari indicated that the risk of missing a diagnosis of SLE is very low when ANA tests are conducted according to the Canadian Rheumatology Association’s recommendations, which advise against ordering antibody serology unless specific signs and symptoms of SLE are present [10]. This evidence concerns the gene BTG3 and systemic lupus erythematosus.